Clinical trials sponsored by University of Athens
3
Recruiting trials
8
Conditions studied
Phase breakdown
Not applicable 3
Conditions studied
| Condition | Trials |
|---|---|
| Type 2 diabetes | 2 |
| Anesthesia | 1 |
| Diabete Type 2 | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Multiple Sclerosis Relapse | 1 |
| Multiple sclerosis | 1 |
| Myocardial Infarction (MI) | 1 |
| Surgery | 1 |
Recruiting trials led by University of Athens
- Postoperative Relapses in MS Patients
- The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
- The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness and Cardiac Deformation After Acute Myocardial Infarction
Common questions
How many trials is University of Athens recruiting for?
University of Athens is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.